Skip to main content

ViaDerma, Inc. Provides Updates on Current Business Activities

Written by Customer Service on . Posted in Public Companies.

The Company has finalized a ten-year $12 million licensing agreement with a Dubai Company

LOS ANGELES, June 24, 2021 (GLOBE NEWSWIRE) — ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to provide an update on current business activities.

  • The Company has finalized a ten-year $12 million licensing agreement in Dubai. Under the terms of the agreement ViaDerma grants licensing rights to sell ViaDerma based products throughout the Middle East. The first semiannual payment of $600,000 has been initiated and will be available to ViaDerma on or before August 5, 2021.
  • ViaDerma’s licensing agreement with a home health wound care network has now expanded to nine states: CA, NV, AZ, TX, TN, GA, OH, FL, IL. As part of the agreement ViaDerma receives royalties of $5000 per month for each state and are on track to reach their target of 16 states by year end. With the newly added state ViaDerma’s monthly revenue from the agreement has increased to $45,000 per month.
  • The Company expects to hire a qualified auditing firm registered with the Public Company Accounting Oversight Board (PCAOB) within the next 30 to 60 days to complete an audit of ViaDerma’s financials. Audited financials are required before ViaDerma can make application for listing on the OTCQB later this year.

About ViaDerma, Inc.
ViaDerma, Inc. (OTC: VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. For more information, visit: www.viadermalicensing.com

Any forecast of future performance is a “forward looking statement” under securities laws. Such statements are included to allow potential investors the opportunity to understand management’s beliefs and opinions with respect to the future so that they may use such beliefs and opinions as one factor among many in evaluating an investment.

Contact information:
Investor Relations
Email:  info@viadermalicensing.com
Phone: 310-734-6111
Follow us on Twitter: ViaDerma Official @viaderma
Like us on Facebook: ViaDerma-VDRM @viadermapharma

 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.